Recent modifications in the management of well‐differentiated thyroid cancer have resulted
in significant alterations in clinical approach. Utilizing a series of preoperative and …

Introduction: Surgical treatment of thyroid cancer has become less aggressive but for many
patients, the threshold for performing total thyroidectomy (TT), as opposed to thyroid …

Many large, retrospective studies have been performed and form the basis for how we
define risk groups of patients with differentiated thyroid carcinoma and how the three basic …

Cancer staging allows patients to be stratified based on aggressiveness of their disease and
provides important prognostic information to both the patient and clinician. The tumor-nodal …

Differentiated thyroid cancer, which includes papillary and follicular histologies, is a common
malignancy and is increasing in incidence. It carries a favorable prognosis compared to …

Background: The well recognized prognostic factors in differentiated carcinoma of the
thyroid are age, grade, extracapsular extension, distant metastasis, and size of the tumor …

Differentiated thyroid cancer (DTC) accounts for 98% of thyroid cancer, with neoplasms
arising from the follicular cells (papillary, follicular and Hurthle cell thyroid cancer) and …

Thyroid cancer represents about 1% of all malignancies but is the most common endocrine
malignant tumour. In the UK the annual incidence is reported to be 2.3 per 100,000 women …

Background Well-differentiated thyroid carcinoma is defined as locally advanced in the
presence of an extra thyroid extension, eg, when the surrounding structures such as the …

Differentiated thyroid cancer (DTC) is being diagnosed with increasing incidence, but the
mortality rate has remained low. The vast majority of these tumors are low-risk cancers …